Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
LATEST NEWS
23 Died After Getting Covid Shot in Norway. Here's the Rest of the Story
By Adam Smith
23 hours ago
LATEST NEWS
Fauci: 100 Million Vaccine Doses in 100 Days Is 'Doable'
By Adam Smith
Jan 17, 2021 2:53 PM EST
INVESTING
Pfizer Slows Non-U.S. Vaccine Deliveries Amid Manufacturing Changes; Boosts 2021 Dose Goal to 2 Billion
By Martin Baccardax
Jan 15, 2021 10:55 AM EST
PRESS RELEASES
Pfizer's XALKORI® (crizotinib) Approved By FDA For ALK-positive Anaplastic Large Cell Lymphoma In Children And Young Adults
By Business Wire
Jan 14, 2021 4:30 PM EST
INVESTING
Johnson & Johnson Single-Shot Vaccine Safe in Trials: Report
By Tom Bemis
Jan 13, 2021 7:42 PM EST
Video
Johnson & Johnson Potential Vaccine Rollout Faces Delays
Jan 13, 2021 9:44 AM EST
INVESTING
Johnson & Johnson One Shot Covid-19 Vaccine Delayed
By M. Corey Goldman
Jan 13, 2021 5:32 PM EST
INVESTING
Pfizer Shares Slip on CEO Bourla's Earnings Estimate
By Dan Weil
Jan 12, 2021 1:40 PM EST
PRESS RELEASES
Vedanta Biosciences Announces $25 Million Investment From Pfizer Inc.
By Business Wire
Jan 12, 2021 6:50 AM EST
PRESS RELEASES
PureTech Founded Entity Vedanta Biosciences Announces $25 Million Investment From Pfizer Inc.
By Business Wire
Jan 12, 2021 6:50 AM EST
PRESS RELEASES
Pfizer Invests $120 Million In Biotechnology Innovation Through The Pfizer Breakthrough Growth Initiative
By Business Wire
Jan 12, 2021 6:45 AM EST
INVESTING
CureVac Covid Vaccine Candidate Shows Progress in Animal Trial
By Tony Owusu
Jan 11, 2021 9:20 AM EST
INVESTING
Moderna Expanding Vaccine Pipelines for Flu, HIV, Nipah
By Rob Lenihan
Jan 11, 2021 8:39 AM EST
PRESS RELEASES
Moderna Provides Business Update And Announces Three New Development Programs In Infectious Disease Vaccines
By Business Wire
Jan 11, 2021 7:20 AM EST
JIM CRAMER
Game Plan: Cramer's 'Mad Money' Recap (Friday 1/8/21)
By Scott Rutt
Jan 8, 2021 8:37 PM EST
MARKETS
Stocks Close at Records as Wall Street Assesses Stimulus Prospects
By Joseph Woelfel
Jan 8, 2021 4:19 PM EST
Video
How Patience Paid Off for Jim Cramer With AbbVie
Jan 8, 2021 9:11 AM EST
INVESTING
Moderna Receives U.K. Authorization for Covid Vaccine
By Dan Weil
Jan 8, 2021 11:37 AM EST
INVESTING
Boeing, Micron, Pfizer, Sarepta - Friday's Premarket Movers
By Vidhi Choudhary
Jan 8, 2021 8:00 AM EST
PRESS RELEASES
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies That Neutralize SARS-CoV-2 With A Mutation Associated With Rapid Transmission
By GlobeNewswire
Jan 8, 2021 5:45 AM EST
MARKETS
Dow 31,000, Boeing, Jobs Report, Pfizer, Micron - 5 Things You Must Know Friday
By Joseph Woelfel
Jan 8, 2021 8:35 AM EST
PRESS RELEASES
Corinne Le Goff, Pharm.D. Will Join Moderna As Chief Commercial Officer On January 19
By Business Wire
Jan 7, 2021 8:00 AM EST
PRESS RELEASES
Pfizer Doses First Participant In Phase 3 Study For Duchenne Muscular Dystrophy Investigational Gene Therapy
By Business Wire
Jan 7, 2021 6:45 AM EST
INVESTING
CureVac Shares Surge on Covid Vaccine Partnership With Bayer
By Martin Baccardax
Jan 7, 2021 9:36 AM EST
PRESS RELEASES
ImaginAb Announces License And Supply Agreement With Pfizer For CD8 ImmunoPET Technology
By PR Newswire
Jan 7, 2021 3:00 AM EST
